Baricitinib for rheumatoid arthritis

1Citations
Citations of this article
17Readers
Mendeley users who have this article in their library.

This artice is free to access.

Abstract

This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To assess the benefits and harms of baricitinib for rheumatoid arthritis.

Cite

CITATION STYLE

APA

Zamora, N. V., Tayar, J. H., Lopez-Olivo, M. A., Christensen, R., & Suarez-Almazor, M. E. (2019). Baricitinib for rheumatoid arthritis. Cochrane Database of Systematic Reviews, 2019(4). https://doi.org/10.1002/14651858.CD013311

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free